Lorundrostat for Hypertension, Autoimmunity After COVID-19, Childhood Cancer Survivor Care, and more

JAMA Editor’s Summary

Lorundrostat for Hypertension, Autoimmunity After COVID-19, Childhood Cancer Survivor Care, and more

Editor’s Summary by Anne Rentoumis Cappola, MD, ScM, Senior Editor of JAMA, the Journal of the American Medical Association, for the , issue.

September 26, 2023

Listen on your favorite player Take me to this show’s page

Newer →

Ischemic Conditioning for Stroke, Risk-Stratifying Pediatric Ovarian Masses, Adherence to CPAP and CV Events, and more

← Older

Muvalaplin Lipoprotein(a) Inhibition, Pediatric Sinusitis Antibiotics, Pregnancy Hypertension Screening, and more

Facebook Twitter Buffer LinkedIn WhatsApp

Lorundrostat for Hypertension, Autoimmunity After COVID-19, Childhood Cancer Survivor Care, and more

Editor’s Summary by Anne Rentoumis Cappola, MD, ScM, Senior Editor of JAMA, the Journal of the American Medical Association, for the September 26, 2023, issue.

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

00:00

00:00